The TruSeq Amplicon - Cancer Panel (TSACP) is a highly multiplexed targeted resequencing assay for detecting somatic mutations across hundreds of mutational hotspots in cancer genomes. TSACP provides a streamlined workflow, including a quality control assay for DNA from formalin-fixed, paraffin-embedded (FFPE) samples, simple bead-based sample normalization, automated cluster generation and paired-end sequencing, and on-instrument data analysis. TSACP enables highly sensitive mutation detection within important genes, including BRAF, KRAS, and EGFR.
Triple Negative Breast Cancer
ABL1 (ABL proto-oncogene 1), ALK (Anaplastic lymphoma kinase), APC (APC Regulator Of WNT Signaling Pathway), ATM (ATM serine/threonine kinase), BRAF (B-raf proto-oncogene), CDH1 (Cadherin 1)
See More ...
Targeted Gene Sequencing (TGS)